Trials / Unknown
UnknownNCT04046315
Early Detection of Cardiac Damage With CMR in Women With Breast Cancer
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 55 (estimated)
- Sponsor
- Radboud University Medical Center · Academic / Other
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
With this study the investigators will assess early cardiac damage by means of Global Longitudinal Strain (GLS) in newly diagnosed breast cancer (BC) patients treated with anthracycline-based chemotherapy, and to investigate whether myocardial damage as measured with T1 / T2 Cardiovascular Magnetic Resonance (CMR) mapping and plasma hs-Troponin T is related to changes in GLS.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | CMR | GLS measurement with CMR |
Timeline
- Start date
- 2020-03-01
- Primary completion
- 2021-03-31
- Completion
- 2021-03-31
- First posted
- 2019-08-06
- Last updated
- 2020-03-16
Locations
1 site across 1 country: Netherlands
Source: ClinicalTrials.gov record NCT04046315. Inclusion in this directory is not an endorsement.